Neuronetics (STIM) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 38.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.73% |
| Dec 31, 2025 | 73.50% |
| Sep 30, 2025 | 31.29% |
| Jun 30, 2025 | 4.85% |
| Mar 31, 2025 | -72.48% |
| Dec 31, 2024 | -171.97% |
| Sep 30, 2024 | 35.53% |
| Jun 30, 2024 | 33.05% |
| Mar 31, 2024 | 58.29% |
| Dec 31, 2023 | 65.82% |
| Sep 30, 2023 | 9.54% |
| Jun 30, 2023 | 47.54% |
| Mar 31, 2023 | 13.09% |
| Dec 31, 2022 | -8.18% |
| Sep 30, 2022 | -14.51% |
| Jun 30, 2022 | -82.26% |
| Mar 31, 2022 | -47.74% |
| Dec 31, 2021 | -146.80% |
| Sep 30, 2021 | -198.97% |
| Jun 30, 2021 | 3.42% |
| Mar 31, 2021 | 5.27% |
| Dec 31, 2020 | 65.69% |
| Sep 30, 2020 | 64.45% |
| Jun 30, 2020 | 1.98% |
| Mar 31, 2020 | 3.56% |
| Dec 31, 2019 | -27.18% |
| Sep 30, 2019 | -45.76% |
| Jun 30, 2019 | -21.98% |
| Mar 31, 2019 | -53.56% |
| Dec 31, 2018 | -5.39% |
| Sep 30, 2018 | -34.06% |
| Jun 30, 2018 | -60.51% |
| Mar 31, 2018 | 31.04% |